XRAY insider trading

Healthcare

DENTSPLY SIRONA Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
1,889
Last 90 days
33
Buys / sells
2% / 5%
Market cap
$2.58B

About DENTSPLY SIRONA Inc.

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers intermittent urinary catheters under the LoFric brand and irrigation systems under the Navina brand. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.

Company website: www.dentsplysirona.com

XRAY insider activity at a glance

FilingIQ has scored 1,889 insider transactions for XRAY since Jan 9, 2015. The most recent filing in our index is dated Dec 31, 2026.

Across the full history, 29 open-market purchases and 86 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on XRAY insider trades is 58.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for XRAY?
FilingIQ tracks 1,889 Form 4 insider transactions for XRAY (DENTSPLY SIRONA Inc.), covering filings from Jan 9, 2015 onwards. 33 of those were filed in the last 90 days.
Are XRAY insiders net buyers or net sellers?
Across the full Form 4 history for XRAY, 29 transactions (2%) were open-market purchases and 86 (5%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does XRAY insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is XRAY in?
DENTSPLY SIRONA Inc. (XRAY) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $2.58B.

Methodology & sources

Every XRAY insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.